Excitotoxicity in the lung: N-Methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 10, 1996, Pages 4688-4692

  Said, Sami I ^a   Berisha, Hasan I ^a   Pakbaz, Hedayatollah ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute lung injury; Adult respiratory distress syndrome; Glutamate receptors; Poly(ADP ribose) synthetase

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 2 AMINO 7 PHOSPHONOHEPTANOIC ACID; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHESIS INHIBITOR; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG MECHANISM; LUNG EDEMA; LUNG PERFUSION; LUNG VENTILATION; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALS; ARGININE; BENZAMIDES; CYCLIC GMP; ENZYME INHIBITORS; LUNG; MAGNESIUM; MALE; MODELS, BIOLOGICAL; N-METHYLASPARTATE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PERFUSION; POLY(ADP-RIBOSE) POLYMERASES; PULMONARY EDEMA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; VASOACTIVE INTESTINAL PEPTIDE;

ANIMALIA;

EID: 0030029791     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.10.4688     Document Type: Article

References (46)

1. Nakanishi, S. (1992) Science 258, 597-603.
2. Malenka, R. C. & Nicoll, R. A. (1993) Trends Neurosci. 16, 521-527.
3. McBain, C. J. & Mayer, M. L. (1994) Physiol. Rev. 74, 723-760.
4. Hollmann, M. & Heinemann, S. (1994) Annu. Rev. Neurosci. 17, 31-108.
5. Gasic, G. P. & Hollmann, M. (1992) Annu. Rev. Neurosci. 54, 507-536.
6. Younkin, D. P., Tang, C.-M., Hardy, M., Reddy, U. R., Shi, Q.-Y., Pleasure, S. J., Lee, V. M.-Y. & Pleasure, D. (1993) Proc. Natl. Acad. Sci. USA 90, 2174-2178.
7. Olney, J. W. (1990) Annu. Rev. Pharmacol. Toxicol. 30, 47-71.
8. Meldrum, B. & Garthwaite, J. (1990) Trends Pharmacol. Sci. 11, 379-387.
9. Beal, F. M. (1992) FASEB J. 6, 3338-3344.
10. DeBoni, U. & McLachlan, D. R. (1985) J. Neurol. Sci. 68, 105-118.
11. Lipton, S. A. & Gendelman, H. E. (1995) N. Engl. J. Med. 332, 934-940.
12. Olney, J. W. (1969) J. Neuropathol. 28, 455-474.
13. Choi, D. W., Koh, J. & Peters, S. (1988) J. Neurosci. 8, 185-196.
14. Choi, D. W. (1991) in Excitatory Amino Acid Antagonists, ed. Meldrum, B. S. (Blackwell Scientific, Oxford), pp. 216-236.
15. Choi, D. W. (1985) Neurosci. Lett. 58, 293-297.
16. Garthwaite, G. & Garthwaite, J. (1986) Neurosci. Lett. 66, 193-198.
17. Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S. & Snyder, S. H. (1991) Proc. Natl. Acad. Sci. USA 88, 6368-6371.
18. Dawson, V. L., Dawson, T. M., Bartley, D. A., Uhl, G. R. & Snyder, S. H. (1993) J. Neurosci. 13, 2651-2661.
19. Izumi, Y., Benz, A. M., Clifford, D. B. & Zorumski, C. F. (1992) Neurosci. Lett. 135, 227-230.
20. Demerlé-Pallardy, C., Lonchampt, M.-O., Chabrier, P.-E. & Braquet, P. (1991) Biochem. Biophys. Res. Commun. 181, 456-464.
21. Zinkand, W. C., Stumpo, R. J., Thompson, C., Patel, J. & Pullman, L. M. (1993) NeuroReport 5, 148-150.
22. Lafon-Cazal, M., Cucasi, M., Gaven, F., Pietri, S. & Bockaert, J. (1993) Neumpharmacology 11, 1259-1266.
23. Hammer, B., Parker, W. D., Jr., & Bennett, J. P., Jr. (1993) NeuroReport. 5, 72-74.
24. Noronha-Dutra, A. A., Epperlein, M. M. & Woolf, N. (1993) FEBS Lett. 321, 59-62.
25. Reynolds, I. J. & Hasting, T. G. (1995) J. Neurosci. 15, 3318-3327.
26. Cosi, C., Suzuki, H., Milani, D., Facci, L., Menegazzi, M., Vantini, G., Kanai, Y. & Skaper, S.D. (1994) J. Neurosci. Res. 39, 38-46.
27. Zhang, J., Dawson, V. L., Dawson, T. M. & Snyder, S. H. (1994) Science 263, 687-689.
28. Berisha, H., Foda, H. D., Sakakibara, H., Trotz, M., Pakbaz, H. & Said, S. I. (1990) Am. J. Physiol. 259, L151-L155.
29. Pakbaz, H., Foda, H. D., Berisha, H. L. Trotz, M. & Said, S. I. (1993) Am. J. Physiol. 265, L369-L373.
30. Kalfin, R., Maulik, N., Engelman, R. M., Cordis, G. A., Milenov, K., Kasakov, L. & Das, D. K. (1994) J. Pharmacol. Exp. Ther. 268, 952-958.
31. Brenneman, D. E., Westbrook, G. L., Fitzgerald, S. P., Ennist, D. L., Elkins, K. L., Ruff, M. R. & Pert, C. B. (1988) Nature (London) 335, 639-642.
32. Pincus, D. W., Di Cicco-Bloom, E. M. & Black, I. B. (1990) Nature (London) 343, 564-570.
33. Sata, T., Kubota, E., Misra, H. P., Mojarad, M., Pakbaz, H. & Said, S. I. (1992) Am. J. Physiol. 262, L147-L152.
34. Harper, J. F. & Brooker, G. (1975) J. Cyclic Nucleotide Res. 1, 207-218.
35. Tukey, J. W. (1968) in Experimental Design: Procedures for Behavioral Sciences, ed. Kirk, R. E. (Brooks/ Cole, Belmont, CA), pp. 87-90.
36. Berisha, B., Pakbaz, H., Absood, A. & Said, S. I. (1994) Proc. Natl. Acad. Sci. USA 91, 7445-7449.
37. Murthy, K. S., Zhang, K.-M., Jin, J.-G., Grider, J. R. & Makhlouf, G. M. (1993) Am. J. Physiol. 265, G660-G671.
38. Imai, T., Hirata, Y., Kanno, K. & Marumo F. (1994) J. Clin. Invest. 93, 543-549.
39. Said, S. I., Berisha, H. I. & Pakbaz, H. (1995) Neuroscience 65, 943-946.
40. Shannon, H. E. & Sawyer, B. D. (1989) J. Pharmacol. Exp. Ther. 251, 518-523.
41. Shigemoto, R., Ohishi, H., Nakanishi, S. & Mizuno, N. (1992) Neurosci. Lett. 144, 229-232.
42. Yoneda, Y. & Ogita, K. (1986) Brain Res. 383, 387-391.
43. Inagaki, N., Kuromi, H., Gonoi, T., Okamoto, Y., Ishida, H., Seino, Y., Kaneko, T., Iwanaga, T. & Seino, S. (1995) FASEB J. 9, 686-691.
44. Sninsky, C. A., Brooderson, R. J., Broome, T. A. & Bergeron, R. J. (1994) Gastroentemlogy 106, A569 (abstr.).
45. Simon, R. P. (1984) Semin. Neurol. 4, 490-496.
46. Reynolds, I. J. & Hastings, T. G. (1995) J. Neurosci. 15, 3318-3327.